Vioxx Maker Settles False Advertising Suit

NEW ORLEANS (MedPage Today) -- Almost a decade after the maker of rofecoxib (Vioxx) pulled the once-blockbuster pain killer from the market, the company settled a class action suit charging it with overselling the benefits of the Cox-2 inhibitor.
Source: MedPage Today Public Health - Category: American Health Source Type: news